We are live on ! Find out more
CTIC

CTI BioPharma Corp. (DE) Common Stock

Delisted

CTIC was delisted on the 23rd of June, 2023.

94 hedge funds and large institutions have $165M invested in CTI BioPharma Corp. (DE) Common Stock in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

567% more call options, than puts

Call options by funds: $1.57M | Put options by funds: $236K

144% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 16

109% more capital invested

Capital invested by funds: $78.9M → $165M (+$85.8M)

80% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 10

9% more funds holding

Funds holding: 8694 (+8)

Holders
94
Holders Change
+8
Holders Change %
+9.3%
% of All Funds
2.47%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
18
Increased
39
Reduced
16
Closed
10
Calls
$1.57M
Puts
$236K
Net Calls
+$1.34M
Net Calls Change
-$112K
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
76
UBS Group
Switzerland
$13K +$12.5K +935 +688%
LPL Financial
77
LPL Financial
California
$13K +$13.3K +1,000 New
CG
78
Cutler Group
California
$12K +$13.3K +994 New
Connor, Clark & Lunn Investment Management (CC&L)
79
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$12K +$13.5K +1,010 New
CLOS
80
Compagnie Lombard Odier SCmA
Switzerland
$10K +$10.7K +800 New
BlackRock
81
BlackRock
New York
$4K
MTIP
82
Magee Thomson Investment Partners
California
$4K
LTFS
83
Ladenburg Thalmann Financial Services
Florida
$1K -$93 -7 -6%
PNC Financial Services Group
84
PNC Financial Services Group
Pennsylvania
$1K
VIA
85
Vantage Investment Advisors
Pennsylvania
$1K
GT
86
Glenmede Trust
Pennsylvania
$1K +$1.96K +147 New
MPWT
87
MassMutual Private Wealth & Trust
Connecticut
$246
Manulife (Manufacturers Life Insurance)
88
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$141 +$5.21K +390 +4%
N
89
Nuveen
North Carolina
$19 +$4.58K +343 +30%
ED
90
Exane Derivatives
France
$1
Millennium Management
91
Millennium Management
New York
-$747K -51,198 Closed
ARTA
92
A.R.T. Advisors
New York
-$243K -16,674 Closed
BCM
93
Bridgeway Capital Management
Texas
-$107K -7,350 Closed
Jacobs Levy Equity Management
94
Jacobs Levy Equity Management
New Jersey
-$68K -4,680 Closed
CCMH
95
Cornerstone Capital Management Holdings
New York
-$42K -2,850 Closed
PCM
96
Prelude Capital Management
New York
-$42K -2,850 Closed
Nomura Holdings
97
Nomura Holdings
Japan
-$38K -2,400 Closed
OAM
98
Oxford Asset Management
United Kingdom
-$15K -1,047 Closed
ICAS
99
Investors Capital Advisory Services
Massachusetts
-$14K -1,000 Closed
Royal Bank of Canada
100
Royal Bank of Canada
Ontario, Canada
-$9.72K -728 -98%

CTIC Hedge Fund Activity: Q4 2015 in Review

94 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q4 2015, worth a combined $165M — up 109% from $78.9M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CTIC positions and 10 closed out — a net gain of 8 holders — while 39 added to existing stakes and 16 trimmed.

The largest buyer was BVF Inc, adding an estimated $45.1M. The largest seller was Teachers Advisors, cutting an estimated $1.09M.

  • 94 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q4 2015, up from 86 in Q3 2015.
  • Funds reported $165M of CTI BioPharma Corp. (DE) Common Stock stock for Q4 2015, up 109% quarter-over-quarter.
  • 18 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q4 2015 and 10 closed out, a net change of +8 holders.
  • The largest CTI BioPharma Corp. (DE) Common Stock buyer in Q4 2015 was BVF Inc, an estimated $45.1M added.
  • The largest CTI BioPharma Corp. (DE) Common Stock seller in Q4 2015 was Teachers Advisors, an estimated $1.09M sold.

Based on aggregated 13F filings for Q4 2015.